Violence against women is a major public health and human rights problem with direct and long-term effects on physical health, mental health, and social functioning. It includes intimate partner violence, sexual violence, stalking, and other forms of coercive harm occurring in homes, workplaces, communities, or institutions. Although the seed topic is framed as mistreatment, the clinical relevance lies in the measurable consequences of gender-based violence on biological stress systems and trauma-related psychopathology.
From a medical standpoint, exposure to violence increases risk for acute injury (bruising, fractures, head trauma), disability, chronic pain syndromes, gynecologic complications, and sexually transmitted infections including HIV. Mechanistically, trauma can impair immune function and disrupt neuroendocrine regulation. The hypothalamic-pituitary-adrenal (HPA) axis, which normally governs cortisol rhythms, may become dysregulated after repeated threat. This can contribute to insomnia, somatic symptoms, fatigue, and metabolic changes. In addition, violent environments can delay care-seeking due to fear, financial dependence, or lack of autonomy, worsening prognosis.
Sexual violence has specific health pathways. It is associated with higher rates of pelvic pain, abnormal gynecologic symptoms, pregnancy complications when coercion or forced sex occurs, and increased risk of miscarriage and adverse birth outcomes. The burden is amplified by barriers to emergency contraception, post-exposure prophylaxis, prophylaxis for other infections, and timely forensic and medical evaluation. Clinicians emphasize documentation, wound care, STI screening, and trauma-informed history-taking to support both health outcomes and legal safety planning.
Psychologically, violence against women is strongly associated with a range of trauma-related conditions. Posttraumatic stress disorder (PTSD) is characterized by intrusion symptoms (unwanted memories, nightmares), persistent avoidance, negative alterations in cognition and mood, and hyperarousal (irritability, startle response, sleep disturbance). However, many individuals present with subthreshold symptoms or related syndromes such as complex PTSD, in which chronic interpersonal trauma produces difficulties with emotional regulation, self-concept, and relationships.
Depression and anxiety are also common. Chronic threat contributes to cognitive distortions (e.g., persistent guilt or shame), anhedonia, and hopelessness. Generalized anxiety may arise from sustained hypervigilance, while panic symptoms can occur in response to cues that resemble the original threat. Substance use disorders may develop as maladaptive coping strategies, reflecting reinforcement of avoidance and emotional numbing.
A key biological framework is the stress response model. Repeated violence can lead to persistent sympathetic activation and inflammatory signaling, which has been implicated in pain, cardiovascular risk, and other somatic sequelae. Trauma can also affect autonomic regulation, raising risk for somatic symptom disorders. Importantly, not all survivors develop psychiatric diagnoses, but exposure increases the probability of comorbidity and functional impairment.
Risk factors at the population level include unequal power dynamics, gender inequality, economic dependence, cultural norms that condone violence, and inadequate protection by institutions. Perpetrator-related factors include coercive control, substance misuse, prior violence, and antisocial traits. Protective factors include social support, safety planning, stable housing, access to legal resources, and culturally competent healthcare.
Evidence-based clinical responses prioritize trauma-informed care. This includes ensuring privacy, obtaining consent, avoiding re-traumatizing questioning, and validating the survivor’s experience. Screening tools for intimate partner violence (IPV) and sexual violence should be used with care, ideally when it is safe to do so. Follow-up should address both immediate injury management and longer-term mental health needs.
Psychotherapeutic interventions with evidence include trauma-focused cognitive behavioral therapy (TF-CBT), prolonged exposure, and EMDR (eye movement desensitization and reprocessing) for PTSD. For depression and anxiety, structured psychotherapy and, when appropriate, pharmacotherapy (such as SSRIs/SNRIs for PTSD and comorbid depression) may be considered. Safety planning is essential; treatment without a safety pathway can be inadequate if ongoing abuse continues.
Public health interventions extend beyond clinical care. Community education to shift norms, bystander programs, and perpetrator accountability reduce prevalence. Integrated services—linking emergency care, sexual assault response teams, IPV advocates, social services, and legal support—improve outcomes. Systems should also address barriers to reporting and documentation, confidentiality concerns, and the need for accessible shelters and long-term support.
Long-term monitoring is critical because physical and psychological effects may emerge or intensify over time. Follow-up visits should assess pain, sleep, reproductive health, screening for STIs when indicated, and mental health symptoms such as PTSD, depression, and anxiety. Survivors may benefit from coordinated multidisciplinary care that treats trauma as both a psychological event and a biologically mediated stress exposure.
Recognizing violence against women as a preventable cause of morbidity and mortality supports an evidence-based approach to diagnosis, intervention, and prevention. Clinicians, public health systems, and policymakers can reduce harm by providing trauma-informed healthcare, ensuring safety, and addressing structural determinants that enable abuse. Source: @PrunedaRud71877
Rudy Pruneda: @RadioGenoa Women are treated worse than a pet ,the world should not put up with this injustice to human rights!. #breaking
— @PrunedaRud71877 May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
